| Financial Year |
March 31 2023 |
| Monetary Funds |
3,007,525,297.41 |
| Held-for-trading Financial Assets |
1,589,086,229.92 |
| Notes Receivable |
-- |
| Accounts Receivable |
269,411,618.97 |
| Advances to Suppliers |
124,168,059.41 |
| Other Receivables |
169,014,237.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,411,182,011.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
155,764,353.13 |
| Total Current Assets |
9,726,151,807.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
31,739,576.51 |
| Investment Properties |
156,775,219.96 |
| Fixed Assetes |
4,130,166,744.16 |
| Under-construction Projects |
9,983,465.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
818,444,498.51 |
| R&D expenses |
-- |
| Goodwill |
57,815,629.13 |
| Long-Term Deferred and Prepaid Expenses |
62,045,346.10 |
| Deferred Income Tax Assets |
463,045,303.78 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
8,838,718,808.66 |
| Total Assets |
18,564,870,616.11 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
415,292,656.10 |
| Accounts Payable |
1,828,562,561.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
121,204,350.73 |
| Taxes Payable |
90,215,829.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,644,374,228.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
579,253,671.48 |
| Other Current Liabilities |
159,519,936.92 |
| Sub-Total of Current Liabilities |
6,180,682,354.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,880,589.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,870,000.00 |
| Deferred Income Tax Liabilities |
257,968,423.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,902,515,023.43 |
| Total Liabilities |
10,083,197,377.93 |
| Paid-In Capital(Or Share Stock) |
293,718,653.00 |
| Capital Surplus |
771,878,781.55 |
| Surplus Reserve |
625,898,331.04 |
| LESS:Treasury Stock |
199,998,325.92 |
| Undistributed Profits |
6,757,848,078.56 |
| Minority Stockholder's Interest |
243,097,617.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,238,575,620.23 |
| Owner's Equity（Stockholder's Equity） |
8,481,673,238.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,564,870,616.11 |
